Accueil/Actions/NYXH

NYXH

USD

Nyxoah SA Ordinary Shares

$5.870+0.010 (0.171%)

Prix en Temps Réel

Healthcare

Medical Instruments & Supplies

Belgique

Graphique des Prix

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$5.860

Haut

$6.058

Bas

$5.850

Volume

0.00M

Fondamentaux de l'Entreprise

Capitalisation Boursière

228.1M

Industrie

Medical Instruments & Supplies

Pays

Belgium

Statistiques de Trading

Volume Moyen

0.13M

Bourse

NGM

Devise

USD

Intervalle sur 52 Semaines

Bas $5.55Actuel $5.870Haut $12.21

Actualités Connexes

22 avr. 2025 · 19:58

PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. ("Nyxoah" or the "Company") (NASDAQ: NYXH). Such investors are advised to ...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

21 avr. 2025 · 15:19

Analyst Upgrades

Stifel Maintains Buy on Nyxoah, Lowers Price Target to $14

Stifel analyst Jonathan Block maintains Nyxoah with a Buy and lowers the price target from $15 to $14.

Stifel Maintains Buy on Nyxoah, Lowers Price Target to $14

16 avr. 2025 · 06:00

GlobeNewswire

Conditional Issuance of Shares

INSIDE INFORMATIONREGULATED INFORMATION Conditional Issuance of Shares Mont-Saint-Guibert, Belgium – April 16, 2025, 8:00 am CET / 2:00 am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah" or the "Company"),

14 avr. 2025 · 22:19

PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. ("Nyxoah" or the "Company") (NASDAQ: NYXH). Such investors are advised to ...

8 avr. 2025 · 13:32

Analyst Upgrades

HC Wainwright & Co. Reiterates Buy on Nyxoah, Maintains $15 Price Target

HC Wainwright & Co. analyst Edward White reiterates Nyxoah with a Buy and maintains $15 price target.

HC Wainwright & Co. Reiterates Buy on Nyxoah, Maintains $15 Price Target

GlobeNewswire

8 avr. 2025 · 05:00

Nyxoah Provides Update on FDA Approvable Letter for Genio System

Nyxoah Provides Update on FDA Approvable Letter for Genio System Expects to meet final FDA requirements for full PMA approval in the second quarter Mont-Saint-Guibert, Belgium – April 8, 2025, 07:00am CET / 1:00am ET –

PR Newswire

7 avr. 2025 · 13:33

NYXH Investors Have Opportunity to Join Nyxoah S.A. Fraud Investigation with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Nyxoah S.A....